What is FDA Project Optimus and How Will it Impact Oncology Drug Development?
47:22
Smarter Clinical Document Automation for Transparency and Disclosure Requirements
55:19
How to Define & Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing
54:26
What Oncology Drug Developers Should Expect from the FDA’s Project Optimus
1:28:43
Modeling and Simulation to Select Oncology Dosages - Session 1
42:12
The Role of Toxicology in FDA-Approved Therapeutics with Julie Castañeda, PhD
1:05:36
Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development
2:43:35
Body Language Expert: Stop Using This, It’s Making People Dislike You, So Are These Subtle Mistakes!
1:00:31